Focus Areas

Diagnostics

DRY EYE DIAGNOSTICS

AXIM is working with two specialized point-of-care (POC) lab testing systems designed specifically to assist eye-care physicians in detecting and quantifying a variety of biomarkers associated with external ocular disorders, such as Dry Eye

COVID-19

AXIM Biotech has developed a rapid (10-minute) serological diagnostic test that detects SARS-CoV-2 neutralizing antibodies (Nabs) which are the antibodies needed to fight COVID-19 within the body.

Diagnostics

CANCER DIAGNOSTICS

Using proprietary polyclonal antibodies in collaboration with world-renowned research and academic centers, we have introduced a prototype diagnostic test that measures levels of QSOX1-L in blood and filed for patent protection.